Puretech Health PLC Company Profile (LON:PRTC)

About Puretech Health PLC

Puretech Health PLC logoPureTech Health plc is a cross-disciplinary healthcare company. The Company operates through two segments: growth stage businesses and project phase businesses. Businesses in the growth stage businesses segment are those whose activities focus on developing products to solve healthcare problems in varied markets. This segment includes subsidiary companies, which include Vedanta Biosciences, Inc., Gelesis, Inc., Akili Interactive Lab, Inc., Tal Medical, Inc., Karuna Pharmaceuticals, Inc., Entrega Inc. and Follica Incorporated. Businesses in the project phase businesses segment are those whose activities are focused on financing, sourcing and creating new product candidates and newly created businesses whose technologies are in the process of validation. This segment includes subsidiary companies, which include The Sync Project Inc., Sonde Health, Inc., Commense Inc., Alivio Therapeutics, Inc., Vor Biopharma Inc., Enlight Biosciences, LLC, Mandara Sciences, LLC and Knode Inc.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: PRTC
  • CUSIP:
Key Metrics:
  • Previous Close: $1.45
  • 50 Day Moving Average: $122.15
  • 200 Day Moving Average: $134.46
  • 52-Week Range: GBX 110.66 - GBX 170
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $269.14M
  • Outstanding Shares: 229,841,000
Additional Links:

Analyst Ratings

Consensus Ratings for Puretech Health PLC (LON:PRTC) (?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: GBX 245

Analysts' Ratings History for Puretech Health PLC (LON:PRTC)
Show:
DateFirmActionRatingPrice TargetDetails
2/24/2017Peel HuntBoost Price TargetBuyGBX 238 -> GBX 259View Rating Details
1/5/2017Jefferies Group LLCReiterated RatingBuyGBX 255View Rating Details
12/21/2016Numis Securities LtdReiterated RatingBuyGBX 220View Rating Details
12/21/2016N+1 SingerReiterated RatingBuyGBX 243View Rating Details
12/21/2016Liberum CapitalReiterated RatingBuyGBX 248View Rating Details
(Data available from 2/24/2015 forward)

Earnings

Earnings History for Puretech Health PLC (LON:PRTC)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Puretech Health PLC (LON:PRTC)
Current Year EPS Consensus Estimate: $-0.290 EPS

Dividends

Dividend History for Puretech Health PLC (LON:PRTC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Puretech Health PLC (LON:PRTC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/28/2016Scardino,Dame MarjorieInsiderBuy5,000GBX 135£6,750
10/26/2015Ito,JoichiInsiderBuy6,650GBX 149£9,908.50
10/9/2015Scardino,MarjorieInsiderBuy6,890GBX 126£8,681.40
9/28/2015Langer,RobertInsiderBuy7,200GBX 135£9,720
9/16/2015LaMattina,JohnInsiderBuy11,000GBX 146£16,060
9/10/2015LaMattina,JohnInsiderBuy5,492GBX 146£8,018.32
9/9/2015LaMattina,JohnInsiderBuy11,000GBX 147£16,170
9/4/2015LaMattina,JohnInsiderBuy11,000GBX 138£15,180
9/3/2015Scardino,MarjorieInsiderBuy10,000GBX 135£13,500
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Puretech Health PLC (LON:PRTC)
DateHeadline
News IconEquity Rundown: Checking the Levels for PureTech Health plc (LSE:PRTC) - BVN (LON:PRTC)
bvnewsjournal.com - February 24 at 8:21 AM
finance.yahoo.com logoPureTech Health to Present at the Cowen and Company 37th Annual Health Care Conference (LON:PRTC)
finance.yahoo.com - February 24 at 8:21 AM
News IconDr. Atul Pande (LON:PRTC)
www.dotmed.com - February 23 at 7:26 PM
uk.finance.yahoo.com logoPureTech Health Appoints Atul Pande M.D., Former SVP at GlaxoSmithKline, as Chief Medical Officer (LON:PRTC)
uk.finance.yahoo.com - February 23 at 8:49 AM
finance.yahoo.com logoVedanta Biosciences Announces Clinical Translational Medicine Collaborations with Stanford University … (LON:PRTC)
finance.yahoo.com - February 17 at 8:06 PM
4-traders.com logoPureTech Health : to Present at the Leerink Partners 6th Annual Global Healthcare Conference (LON:PRTC)
www.4-traders.com - February 17 at 8:06 PM
trustnet.com logoPureTech's Vedanta Announces 2 New Collaborations (LON:PRTC)
www.trustnet.com - February 17 at 8:06 PM
News IconPureTech Health plc Company Profile (LON:PRTC)
www.bioportfolio.com - February 8 at 2:56 AM
trustnet.com logoPureTech to Present at Leerink Conference (LON:PRTC)
www.trustnet.com - February 8 at 2:56 AM
uk.finance.yahoo.com logoPureTech Health to Present at the Leerink Partners 6th Annual Global Healthcare Conference (LON:PRTC)
uk.finance.yahoo.com - February 7 at 8:47 AM
News IconVolatility Watch on Shares of PureTech Health plc (LSE:PRTC) - Gilbert Daily (LON:PRTC)
gilbertdaily.com - January 30 at 8:20 AM
capitalcube.com logoPureTech Health Plc breached its 50 day moving average in a Bearish Manner : PRTC-GB : January 25, 2017 (LON:PRTC)
www.capitalcube.com - January 26 at 2:01 AM
News IconValue Composite Score Update on PureTech Health plc (LSE:PRTC) - The Tribune (LON:PRTC)
lakecitytribune.com - January 23 at 7:40 PM
capitalcube.com logoPureTech Health Plc – Value Analysis (LONDON:PRTC) : January 10, 2017 (LON:PRTC)
www.capitalcube.com - January 10 at 8:18 PM
capitalcube.com logoPureTech Health Plc breached its 50 day moving average in a Bullish Manner : PRTC-GB : January 9, 2017 (LON:PRTC)
www.capitalcube.com - January 9 at 5:05 AM
News IconThe Puretech Health PLC (PRTC) Price Target Raised to GBX 248 (LON:PRTC)
viveremilano.biz - December 22 at 7:42 PM
News IconResearch Update: Two Studies from Tal Medical - Satellite PR News (press release) (LON:PRTC)
satprnews.com - December 20 at 1:57 PM
News IconPuretech Health PLC (PRTC) PT Raised to GBX 248 at Liberum Capital (LON:PRTC)
prensariotiretail.com - December 15 at 9:07 PM
finance.yahoo.com logoKaruna Pharmaceuticals and PureTech Health Announce Positive Results from Tolerability Proof-of-Concept Study of KarXT, Being Developed for Schizophrenia and Alzheimer's (LON:PRTC)
finance.yahoo.com - December 15 at 9:07 PM
News IconThe Dialight Plc (DIA) PT Raised to GBX 724 at the Macquarie (LON:PRTC)
myhealthbowl.com - December 13 at 12:29 AM
marketexclusive.com logoAnalyst Activity – Peel Hunt Reiterates Buy on Puretech Health PLC (LON:PRTC) (LON:PRTC)
marketexclusive.com - December 12 at 7:28 PM
News IconPureTech's Akili and Pfizer Present Positive Data - Satellite PR News (press release) (LON:PRTC)
satprnews.com - December 11 at 6:23 PM
trustnet.com logoPureTech's Gelesis Presents Data at ObesityWeek (LON:PRTC)
www.trustnet.com - November 4 at 10:40 AM
finance.yahoo.com logoAdministration of Gelesis200 Increases Fullness and Satiety in People who are Overweight or Have Obesity (LON:PRTC)
finance.yahoo.com - November 4 at 10:40 AM
investingnews.com logoPureTech Health to Present at the Jefferies 2016 Healthcare Conference (LON:PRTC)
investingnews.com - November 2 at 7:12 PM
uk.finance.yahoo.com logoPureTech Health to Present at the Jefferies 2016 Healthcare Conference in London (LON:PRTC)
uk.finance.yahoo.com - November 2 at 10:30 AM
News IconVedanta Biosciences Granted First European Patent Broadly Covering Pharmaceutical Compositions for Microbiome Therapeutics Ba... (LON:PRTC)
uk.advfn.com - October 20 at 7:09 PM
News IconVedanta Biosciences Granted First European Patent Broadly Covering Pharmaceutical Compositions ... (LON:PRTC)
www.biomedreports.com - October 20 at 8:16 AM
finance.yahoo.com logoPureTech Appoints Industry Leader Joseph Bolen as Chief Scientific Officer (LON:PRTC)
finance.yahoo.com - October 20 at 8:16 AM
uk.finance.yahoo.com logoVedanta Biosciences Granted First European Patent Broadly Covering Pharmaceutical Compositions for Microbiome Therapeutics Based on Bacterial Consortia (LON:PRTC)
uk.finance.yahoo.com - October 19 at 3:26 PM
capitalcube.com logoPureTech Health Plc – Value Analysis (LONDON:PRTC) : September 29, 2016 (LON:PRTC)
www.capitalcube.com - September 29 at 12:01 PM
capitalcube.com logoPureTech Health Plc breached its 50 day moving average in a Bearish Manner : PRTC-GB : September 28, 2016 (LON:PRTC)
www.capitalcube.com - September 28 at 12:03 PM
trustnet.com logoPureTech Health PLC (PRTC) (LON:PRTC)
www.trustnet.com - September 27 at 11:30 AM
finance.yahoo.com logoKaruna Doses First Subject in Tolerability Proof-of-Concept Study of Lead Product Candidate (LON:PRTC)
finance.yahoo.com - September 12 at 11:31 AM
proactiveinvestors.co.uk logoRedrow all the rage with brokers after results (LON:PRTC)
www.proactiveinvestors.co.uk - September 7 at 10:25 AM
biz.yahoo.com logoHalf Year 2016 PureTech Health PLC Earnings Release - Time Not Supplied (LON:PRTC)
biz.yahoo.com - September 7 at 10:25 AM
News IconVedanta Biosciences Granted Third U.S. Patent Covering Methods of Treating Infectious & Allergic Diseases with Bacterial Cons... (LON:PRTC)
uk.advfn.com - September 6 at 6:58 PM
trustnet.com logoVedanta Biosciences Granted Third U.S. Patent (LON:PRTC)
www.trustnet.com - September 6 at 6:58 PM
finance.yahoo.com logoVedanta Biosciences Granted Third U.S. Patent Covering Methods of Treating Infectious and Allergic Diseases with Bacterial Consortia (LON:PRTC)
finance.yahoo.com - September 6 at 11:39 AM
capitalcube.com logoPureTech Health Plc breached its 50 day moving average in a Bearish Manner : PRTC-GB : September 5, 2016 (LON:PRTC)
www.capitalcube.com - September 5 at 10:59 AM
finance.yahoo.com logoGelesis Appoints New Chief Operating Officer (LON:PRTC)
finance.yahoo.com - September 2 at 11:46 AM
ft.com logoVedanta Biosciences Granted Second U.S. Patent (LON:PRTC)
announce.ft.com - August 24 at 9:57 AM
News IconVedanta Biosciences Granted Second U.S. Patent Covering Methods of Treating Autoimmune Disease with Therapeutics Based on Bac... (LON:PRTC)
uk.advfn.com - August 24 at 9:57 AM
finance.yahoo.com logoVedanta Biosciences Granted Second U.S. Patent Covering Methods of Treating Autoimmune Disease with Therapeutics Based on Bacterial Consortia (LON:PRTC)
finance.yahoo.com - August 23 at 11:27 AM
News IconVedanta Biosciences Granted U.S. Patent Broadly Covering Pharmaceutical Compositions for Microbiome Therapeutics Based on Bac... (LON:PRTC)
uk.advfn.com - August 16 at 7:03 PM
trustnet.com logoPureTech's Vedanta Biosciences Granted US Patent (LON:PRTC)
www.trustnet.com - August 16 at 7:03 PM
uk.finance.yahoo.com logoVedanta Biosciences Granted U.S. Patent Broadly Covering Pharmaceutical Compositions for Microbiome Therapeutics Based on Bacterial Consortia (LON:PRTC)
uk.finance.yahoo.com - August 16 at 10:10 AM
capitalcube.com logoPureTech Health Plc :PRTC-GB: Earnings Analysis: 2015 By the Numbers : August 12, 2016 (LON:PRTC)
www.capitalcube.com - August 12 at 10:06 AM
stockhouse.com logoVedanta and NYU Langone Medical Center Collaborate (LON:PRTC)
www.stockhouse.com - August 11 at 10:10 AM
uk.finance.yahoo.com logoVedanta Biosciences Announces Collaboration with the NYU Langone Medical Center to Develop Microbiome-Derived Immunotherapies for Cancer (LON:PRTC)
uk.finance.yahoo.com - August 11 at 10:10 AM

Social

What is Puretech Health PLC's stock symbol?

Puretech Health PLC trades on the London Stock Exchange (LON) under the ticker symbol "PRTC."

Where is Puretech Health PLC's stock going? Where will Puretech Health PLC's stock price be in 2017?

5 brokerages have issued 12-month price targets for Puretech Health PLC's stock. Their forecasts range from GBX 220 to GBX 259. On average, they anticipate Puretech Health PLC's stock price to reach GBX 245 in the next year.

How do I buy Puretech Health PLC stock?

Shares of Puretech Health PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How much does a share of Puretech Health PLC stock cost?

One share of Puretech Health PLC stock can currently be purchased for approximately GBX 115.38.


Last Updated on 2/24/2017 by MarketBeat.com Staff